Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis

Area of Science:

• Molecular Biology
• Hematology
• Genetics

Background:

• Alternative splicing expands proteome diversity and is fundamental to stem cell research and cellular differentiation.
• Aberrant splicing, as seen in thalassemias, highlights the impact of genetic mutations on gene expression.
• Hematopoiesis, the process of blood cell formation, is a well-established field benefiting from technological advancements.

Purpose of the Study:

• To review novel technologies for studying alternative splicing in hematopoiesis.
• To highlight key alternative splicing events and regulators critical for blood cell development.
• To provide an overview of how splicing factor mutations contribute to hematologic malignancies.

Main Methods:

• Integration of multicolor flow cytometry with bulk and single-cell sequencing technologies.
• Analysis of alternative splicing events in the context of normal hematopoiesis and disease.
• Review of genetic studies linking splicing factor mutations to myeloid malignancies.

Main Results:

• Advanced technologies offer sophisticated insights into blood system regulation.
• Splicing factor mutations are recognized drivers of myeloid malignancies, particularly myelodysplastic syndromes.
• Alternative splicing plays essential roles in maintaining hematopoietic stem cells and differentiation.

Conclusions:

• Alternative splicing is a critical mechanism in hematopoiesis with implications for disease.
• Understanding splicing factor mutations is key to developing therapies for hematologic malignancies.
• Novel technologies are revolutionizing the study of splicing in blood disorders.